AI Verdict
RAL has stronger fundamentals based on our AI analysis.
RAPP vs RAL Fundamental Comparison
| Metric | RAPP | RAL |
|---|---|---|
| Revenue | N/A | $2.1B |
| Net Income | $-111.5M | $-1.2B |
| Net Margin | N/A | -59.1% |
| ROE | -23.0% | -74.8% |
| ROA | -21.8% | -32.0% |
| Current Ratio | 26.17x | 0.84x |
| Debt/Equity | 0.00x | 0.70x |
| EPS | $-2.86 | $-10.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RAPP vs RAL: Frequently Asked Questions
Is RAPP or RAL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RAL has stronger fundamentals. RAPP is rated STRONG SELL (78% confidence) while RAL is rated STRONG SELL (82% confidence). This is not investment advice.
How does RAPP compare to RAL fundamentally?
Rapport Therapeutics, Inc. has ROE of -23.0% vs Ralliant Corp's -74.8%. Net margins are N/A vs -59.1% respectively.
Which stock pays higher dividends, RAPP or RAL?
RAPP has a dividend yield of N/A or no dividend while RAL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RAPP or RAL for long term?
For long-term investing, consider that RAPP has STRONG SELL rating with 78% confidence, while RAL has STRONG SELL rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RAPP vs RAL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RAPP vs RAL, the AI consensus favors RAL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.